Literature DB >> 6692212

Tuberculosis and nonsteroidal anti-inflammatory drugs.

H O Tomasson, M Brennan, M J Bass.   

Abstract

In 1980 and 1982 two case reports documented reactivation of pulmonary tuberculosis in patients who had used nonsteroidal anti-inflammatory drugs (NSAIDs). A case-control study was designed to test the hypothesis that such an association does exist. Data for 38 patients were obtained from the patients' family physicians, and each patient was matched with a control from the same practice for age, sex, race and length of time in that practice. A statistically significant relation was found between the reactivation of tuberculosis and the use of NSAIDs. However, further research is imperative to determine whether the association is direct, indirect or secondary to an unknown factor. Physicians should keep in mind that NSAIDs are potent anti-inflammatory agents and may thus activate, spread and mask infections.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6692212      PMCID: PMC1875351     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  15 in total

1.  THE PATHOGENESIS OF PULMONARY TUBERCULOSIS AMONG OLDER PERSONS.

Authors:  W W STEAD
Journal:  Am Rev Respir Dis       Date:  1965-06

2.  Tuberculosis occurring during steroid therapy.

Authors:  J MACKINNON
Journal:  Br Med J       Date:  1959-12-19

3.  Activation of latent infection by indomethacin: a report of three cases.

Authors:  L Solomon
Journal:  Br Med J       Date:  1966-04-16

4.  Tuberculosis occurring in association with corticosteroid treatment.

Authors:  R B MAYFIELD
Journal:  Tubercle       Date:  1962-03

Review 5.  Species differences and the clinical trial of new drugs: a review.

Authors:  T Koppanyi; M A Avery
Journal:  Clin Pharmacol Ther       Date:  1966 Mar-Apr       Impact factor: 6.875

Review 6.  The immunology of tuberculosis.

Authors:  F M Collins
Journal:  Am Rev Respir Dis       Date:  1982-03

Review 7.  Drug therapy: nonsteroidal antiinflammatory drugs (first of two parts).

Authors:  L S Simon; J A Mills
Journal:  N Engl J Med       Date:  1980-05-22       Impact factor: 91.245

8.  Activation of latent tuberculosis by nonsteroidal anti-inflammatory agents.

Authors:  M Brennan
Journal:  Can Med Assoc J       Date:  1980-02-23       Impact factor: 8.262

9.  Sudden death in arthritic children receiving large doses of indomethacin.

Authors:  J S Jacobs
Journal:  JAMA       Date:  1967-03-20       Impact factor: 56.272

10.  Improved survival in the suckling rat model of group B streptococcal sepsis after treatment with nonsteroidal anti-inflammatory drugs.

Authors:  B L Short; M K Miller; J R Fletcher
Journal:  Pediatrics       Date:  1982-09       Impact factor: 7.124

View more
  7 in total

1.  Adverse effects of NSAIDs.

Authors:  P J Rooney; W F Kean; Y B Kassam; M R Asch
Journal:  Can Med Assoc J       Date:  1985-03-15       Impact factor: 8.262

2.  Adverse effects of NSAIDs on renal function.

Authors:  M Brennan
Journal:  Can Med Assoc J       Date:  1984-11-01       Impact factor: 8.262

Review 3.  Crohn's disease and the mycobacterioses: a review and comparison of two disease entities.

Authors:  R J Chiodini
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

4.  Mycobacterial granulomatous inflammation in the ulcerated caecum of indomethacin-treated rats.

Authors:  A Anthony; A P Dhillon; H Fidler; J McFadden; O Billington; G Nygard; R E Pounder; A J Wakefield
Journal:  Int J Exp Pathol       Date:  1995-04       Impact factor: 1.925

5.  Risk of incident active tuberculosis disease in patients treated with non-steroidal anti-inflammatory drugs: a population-based study.

Authors:  Chun-Wei Wu; Jiunn-Yih Wu; Meng-Tse Gabriel Lee; Chih-Cheng Lai; I-Lin Wu; Yi-Wen Tsai; Shy-Shin Chang; Chien-Chang Lee
Journal:  BMC Pulm Med       Date:  2017-05-04       Impact factor: 3.317

6.  Cyclooxygenase inhibitors impair CD4 T cell immunity and exacerbate Mycobacterium tuberculosis infection in aerosol-challenged mice.

Authors:  Rasmus Mortensen; Helena Strand Clemmensen; Joshua S Woodworth; Marie Louise Therkelsen; Tehmina Mustafa; Kristian Tonby; Synne Jenum; Else Marie Agger; Anne Ma Dyrhol-Riise; Peter Andersen
Journal:  Commun Biol       Date:  2019-08-05

Review 7.  The Manipulation of the Lipid Mediator Metabolism as Adjunct Host-Directed Therapy in Tuberculosis.

Authors:  Arista Nienaber; Frank E A Hayford; Ebrahim Variava; Neil Martinson; Linda Malan
Journal:  Front Immunol       Date:  2021-03-12       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.